Strides Pharma Science Ltd. has issued a clarification regarding the recent increase in trading volume of its equity shares. The company confirms it adheres to all regulatory compliance standards. It states that it is unaware of any undisclosed information that could affect share prices. The company believes the share movement is market-driven, emphasizing its commitment to transparency and compliance.
Response to Trading Volume Increase
Strides Pharma Science Ltd. has addressed recent queries regarding a notable surge in the trading volume of its equity shares. In a statement released on February 2, 2026, the company provided clarity on the matter.
Compliance Confirmation
The company asserts that it is in full compliance with all applicable regulations. All material information and disclosures have been appropriately communicated to the stock exchanges in a timely manner.
Market-Driven Movement
According to the company’s assessment, the fluctuations observed in the trading volume of its shares appear to be driven by market dynamics. Strides Pharma Science Ltd. stated that it possesses no specific undisclosed information or explanation for the said movement beyond what has already been disclosed to the exchanges. The company reiterated that it is not aware of any pending announcements or information that could be influencing the volume of shares.
Source: BSE
